Divtrida 300 mg FC tablet
PDF Leaflet Revision Date: 31 August 2018
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV infection in adults aged 18 years and older.
Dosage (summary)
One tablet orally once daily.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; potential risks include neural tube defects.
Key Drug Interactions
- Metformin
- Dofetilide
- Polyvalent cation-containing antacids
Contraindications
- Hypersensitivity to components
- Renal impairment
- Pregnancy
- Lactation
- Moderate to severe hepatic impairment
Common side effects
- Nausea
- Headache
- Fatigue
- Rash
- Renal insufficiency
Counselling Points
- Monitor for signs of lactic acidosis
- Use effective contraception
- Regular renal function tests recommended
Serious warnings
- Lactic acidosis
- Severe hepatomegaly
- Immune Reconstitution Inflammatory Syndrome
Important Disclaimer
The Divtrida 300 mg FC tablet professional information leaflet below is the property of Novagen Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
